Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 2
2017 5
2018 1
2019 2
2020 8
2021 18
2022 15
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Predicting the efficacy of first-line immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancer.
Miyawaki T, Naito T, Doshita K, Kodama H, Mori M, Nishioka N, Iida Y, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono A, Kenmotsu H, Murakami H, Mori K, Harada H, Endo M, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: mamesaya n. Thorac Cancer. 2022 Jul;13(14):2064-2074. doi: 10.1111/1759-7714.14529. Epub 2022 Jun 13. Thorac Cancer. 2022. PMID: 35698259 Free PMC article. Review.
Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
Noda-Narita S, Naito T, Udagawa H, Goto K, Miyawaki T, Mamesaya N, Nakashima K, Kenmotsu H, Shimokawaji T, Kato T, Hakozaki T, Okuma Y, Nakamura M, Nakayama Y, Watanabe H, Kusumoto M, Ohe Y, Horinouchi H. Noda-Narita S, et al. Among authors: mamesaya n. Cancer Sci. 2022 Oct 26. doi: 10.1111/cas.15621. Online ahead of print. Cancer Sci. 2022. PMID: 36285515 Free article.
Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer.
Nishimura A, Ono A, Wakuda K, Kawabata T, Yabe M, Miyawaki T, Miyawaki E, Kodama H, Nishioka N, Mamesaya N, Kobayashi H, Omori S, Kenmotsu H, Naito T, Murakami H, Harada H, Takahashi T. Nishimura A, et al. Among authors: mamesaya n. Invest New Drugs. 2022 Apr;40(2):464. doi: 10.1007/s10637-021-01198-z. Invest New Drugs. 2022. PMID: 34748131 Free PMC article. No abstract available.
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis.
Takinami M, Ono A, Kawabata T, Mamesaya N, Kobayashi H, Omori S, Wakuda K, Kenmotsu H, Naito T, Murakami H, Endo M, Kiyohara Y, Yasui H, Niwakawa M, Takahashi T. Takinami M, et al. Among authors: mamesaya n. Invest New Drugs. 2021 Dec;39(6):1716-1723. doi: 10.1007/s10637-021-01136-z. Epub 2021 May 28. Invest New Drugs. 2021. PMID: 34046801 Free PMC article.
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis.
Doshita K, Kenmotsu H, Omori S, Tabuchi Y, Kawabata T, Kodama H, Nishioka N, Miyawaki E, Iida Y, Miyawaki T, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Kaneko T, Takahashi T. Doshita K, et al. Among authors: mamesaya n. Invest New Drugs. 2022 Apr;40(2):411-419. doi: 10.1007/s10637-021-01183-6. Epub 2021 Oct 30. Invest New Drugs. 2022. PMID: 34716848
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.
Omori S, Muramatsu K, Kawata T, Miyawaki E, Miyawaki T, Mamesaya N, Kawamura T, Kobayashi H, Nakashima K, Wakuda K, Ono A, Kenmotsu H, Naito T, Murakami H, Sugino T, Takahashi T. Omori S, et al. Among authors: mamesaya n. J Cancer Res Clin Oncol. 2022 Sep;148(9):2455-2463. doi: 10.1007/s00432-021-03784-3. Epub 2021 Sep 17. J Cancer Res Clin Oncol. 2022. PMID: 34533624
Impact of losing adipose tissue on outcomes from PD-1/PD-L1 inhibitor monotherapy in non-small cell lung cancer.
Nishioka N, Naito T, Miyawaki T, Yabe M, Doshita K, Kodama H, Miyawaki E, Iida Y, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono A, Kenmotsu H, Murakami H, Takayama K, Takahashi T. Nishioka N, et al. Among authors: mamesaya n. Thorac Cancer. 2022 May;13(10):1496-1504. doi: 10.1111/1759-7714.14421. Epub 2022 Apr 14. Thorac Cancer. 2022. PMID: 35420262 Free PMC article.
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer.
Nishimura A, Ono A, Wakuda K, Kawabata T, Yabe M, Miyawaki T, Miyawaki E, Kodama H, Nishioka N, Mamesaya N, Kobayashi H, Omori S, Kenmotsu H, Naito T, Murakami H, Harada H, Takahashi T. Nishimura A, et al. Among authors: mamesaya n. Invest New Drugs. 2022 Apr;40(2):403-410. doi: 10.1007/s10637-021-01191-6. Epub 2021 Oct 11. Invest New Drugs. 2022. PMID: 34633575 Free PMC article.
43 results